Showing BioInteractions for Cetuximab (DB00002)
BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Cetuximab is a Epidermal growth factor receptor binder | ||
| 1 | Epidermal growth factor receptor antagonists | Erlotinib, Gefitinib, Icotinib, Lapatinib, Lidocaine, Necitumumab, Zalutumumab |
| 2 | Epidermal growth factor receptor suppressors | Panitumumab |
| 3 | Epidermal growth factor receptor inhibitors | Abivertinib, Afatinib, Brigatinib, Dacomitinib, Fostamatinib, Neratinib, Olmutinib, Osimertinib, Vandetanib, Zanubrutinib |
| 4 | Epidermal growth factor receptor agonists | Foreskin keratinocyte (neonatal) |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Cetuximab is a Low affinity immunoglobulin gamma Fc region receptor III-B binder | ||
| 1 | Low affinity immunoglobulin gamma Fc region receptor III-B ligands | Etanercept |
| 2 | Low affinity immunoglobulin gamma Fc region receptor III-B antagonists | Human immunoglobulin G |
| 3 | Low affinity immunoglobulin gamma Fc region receptor III-B agonists | Catumaxomab |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Cetuximab is a Complement C1q subcomponent subunit A binder | ||
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Cetuximab is a Complement C1q subcomponent subunit B binder | ||
| 1 | Complement C1q subcomponent subunit B modulators | Zinc chloride, Zinc sulfate, unspecified form |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Cetuximab is a Complement C1q subcomponent subunit C binder | ||
| 1 | Complement C1q subcomponent subunit C modulators | Zinc chloride, Zinc sulfate, unspecified form |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Cetuximab is a Low affinity immunoglobulin gamma Fc region receptor III-A binder | ||
| 1 | Low affinity immunoglobulin gamma Fc region receptor III-A ligands | Etanercept |
| 2 | Low affinity immunoglobulin gamma Fc region receptor III-A antagonists | Human immunoglobulin G |
| 3 | Low affinity immunoglobulin gamma Fc region receptor III-A bindings | Benralizumab |
| 4 | Low affinity immunoglobulin gamma Fc region receptor III-A agonists | Catumaxomab |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Cetuximab is a High affinity immunoglobulin gamma Fc receptor I binder | ||
| 1 | High affinity immunoglobulin gamma Fc receptor I antagonists | Human immunoglobulin G, Porfimer sodium |
| 2 | High affinity immunoglobulin gamma Fc receptor I binders | Atomoxetine |
| 3 | High affinity immunoglobulin gamma Fc receptor I ligands | Etanercept |
| 4 | High affinity immunoglobulin gamma Fc receptor I agonists | Catumaxomab |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| Cetuximab is a Low affinity immunoglobulin gamma Fc region receptor II-a binder | ||
| 1 | Low affinity immunoglobulin gamma Fc region receptor II-a ligands | Etanercept |
| 2 | Low affinity immunoglobulin gamma Fc region receptor II-a antagonists | Human immunoglobulin G |
| 3 | Low affinity immunoglobulin gamma Fc region receptor II-a agonists | Catumaxomab |